Docket: 03N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk-Based Approach Comment Number: EC -15
Accepted - Volume 1
Comment Record
Commentor
Mrs. G.Sundar Sundaram
Date/Time
2003-03-17 05:09:32
Organization
Cipla ltd
Category
Company
Comments for FDA General
Questions
1. General Comments
Pl provide details of risk based approach on
bulk drugs and synthetics chemicals. pl tell me the gudelines and criterion for risk based cgmp